Oct 23, 2023 · 2 min read

Listen: The “Huberman Lab” Podcast with Priscilla Chan and Mark Zuckerberg

Priscilla Chan and Mark Zuckerberg talk with neuroscientist Andrew Huberman about CZI’s science work, including how AI will help us better understand disease, and the recent launches of the Chicago and New York Biohubs.

Andrew Huberman sits across a table from Priscilla Chan and Mark Zuckerberg. All three speak to each other and into microphones.
Andrew Huberman chats with Priscilla Chan and Mark Zuckerberg. | Photograph by Mike Blabac.

Priscilla Chan and Mark Zuckerberg, co-founders and co-CEOs of the Chan Zuckerberg Initiative, joined Andrew Huberman, neuroscientist and tenured professor at Stanford School of Medicine, to talk about CZI and the Chan Zuckerberg Biohub Network on the “Huberman Lab” podcast. They discussed CZI’s mission to help scientists cure, prevent, or manage all diseases by the end of this century, as well as how advances in artificial intelligence will help achieve this goal. Priscilla and Mark also shared the inspiration behind the CZ Biohub Network, and how the Chicago and New York Biohubs will push the bounds of scientific discovery.

“Where I always found the most hope as a physician is new discoveries, new opportunities, and new ways of understanding how to keep people well, which come from basic science,” said Priscilla Chan.

Listen to the podcast, and learn more about the CZ Biohub Network.


About the Chan Zuckerberg Initiative
The Chan Zuckerberg Initiative was founded in 2015 to help solve some of society’s toughest challenges — from eradicating disease and improving education, to addressing the needs of our communities. Through collaboration, providing resources and building technology, our mission is to help build a more inclusive, just and healthy future for everyone. For more information, please visit chanzuckerberg.com.

Amazon To Debut CZI-Supported Award-Winning Documentary, "For Love & Life: No Ordinary Campaign"
CZI Launches AI Advisory Group and Residency Program To Accelerate Development of Virtual Cell Models